Legislation
- Title
- Health Insurance - Prior Authorization for Drug Products to Treat an Opioid Use Disorder - Prohibition
- Sponsored by
- Delegates Pena-Melnyk, Angel, Barron, Kelly, McMillan, Tarlau, Bromwell, Cullison, Hayes, Hill, Kipke, Krebs, McDonough, Metzgar, Miele, Morales, Morgan, Pendergrass, Platt, Rosenberg, Saab, Sample-Hughes, Szeliga, West, K. Young, and Frick
- Status
- Approved by the Governor - Chapter 581
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Prohibiting specified insurers, nonprofit health service plans, and health maintenance organizations from applying a preauthorization requirement for a prescription drug to be used for treatment of an opioid use disorder and that contains methadone, buprenorphine, or naltrexone; and applying the Act to all policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or after the effective date of the Act.
Committees
Details
Emergency Bill
Bill File Type: Regular
Effective Date(s): Upon Enactment
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
(
15-850 )
Last Updated: 2/3/2020 2:31 PM